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Abstract:  
Studies pertaining to drug-DNA interactions in treating a disease efficiently have taken an important place in recent times. Murthy and 
colleagues were active in correlating the drug activity, with physical parameters like refractivity, susceptibility, molecular electron 
ionization cross-section and the dosage. The molecular polarizability, diamagnetic susceptibility and molecular electron ionization 
cross section Q have been evaluated. An analysis of Q in the light of the data available on plasma protein binding, bio availability, Log 
P and half-Life show semblance of regular dependence of Q on them and hence an effort is made to bring this dependence into a 
regular mathematical relationship.  The dosage of each drug is calculated.  A critical look at the results arrived on Q and dosages 
reveal that a highly active drug with large Q need to be monitored in very small quantities and any minute increase in dosage is 
resulting in unwanted toxic effects and vice versa. The algebraic formulae enable one to calculate the dosages theoretically from the 
value of Q  and other parameters and the calculated dosage  through the formulae agreed favorably well with  suggested dosages. For 
example, in primaquine phosphate, the calculated dosage is 30 mg per day against the suggested practical dosage of 26.3 mg per day.  
A similar observation is made in mepacrine with theoretical dosage of 60 mg per day as against the suggested practical dosage of 100 
mg per day.  In short, the molecular structure followed by refraction and susceptibility measurements and Q will throw light on 
dosage, toxicity of a drug. Thus the present investigations pave way for a new direction of approach for study of drug activity without 
recourse to techniques involving highly expensive instrumentation and highly theoretical approaches involving quantum mechanical 
methods.  
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Background:  
The constant pursuit in pharmacology and pharmaco chemistry 
is to study how efficiently a drug acts to treat a particular 
disease. Usually many physico-chemical and quantum 
mechanical methods as well as physical techniques like IR, 
Raman etc., have been used to study drug-DNA interactions. 
The drug-DNA interaction studies have acquired a lot of 
importance in recent days owing to dreadful diseases like AIDS, 
cancer and Alzheimer’s. Murthy and colleagues [1-11] were 
active in correlating the drug activity with physical parameters 
like electron ionization cross-section and λm. 
 
The present work is an extension of the same made to 
antimalarials, starting from evaluation of polarizabilities αM, 
susceptibilities  χM  and molecular electron ionisation cross-
section  [15]
  Q to the drug activity and dosage through an 
algebraic expression 11, utilising the data of medicinal 
parameters the dosages thus obtained are correlated with 
experimental values. The required parameters are taken from 
references 5-14.   
 
Methodology: 
Many physico-chemical as well as quantum mechanical 
techniques are in vogue in studying drug-DNA interactions. An 
attempt is made by Murthy and his colleagues since 1995 to 
correlate the molecular electron ionization cross-section with the 
dosage of the medicine and the toxic effects. The physical 
parameters like electronic polarizability, diamagnetic 
susceptibilities and molecular electron ionization cross-section 
are utilized in evaluating the dosage of a drug. The above 
parameters are obtained through quantum mechanical approach 
of Lippincott, bond polarizability and bond refractivity of Le 
Fevre [1]
 and also by the molecular dynamic method. 
 
The molecular dynamic method is considered to be highly 
sensitive to conformational changes and so is taken as standard.  
The very fact of studying these physical properties of medically 
important compounds is to show the usefulness of these methods 
in correlating molecular electron ionization cross-section with 
dosage and using the data of protein binding PB, bio availability 
BA, half life HL and Log P in calculating the dosage and toxic 
effect of drug through an algebraic formula described in 
equation 11. 
 
The mean polarizability of these drugs have been experimentally 
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theoretical approaches of Lippincott and Stutman [13, 14] 
additivity of bond refractions and molecular force field studies.  
 
The details of these approaches are given in the earlier papers of 
Murthy. [1-6] The formulae for polarizabilities, susceptibilities 
and electron ionization cross-sections are given in equations 1 to 
10 (see supplementary material). The parameters used in 
equations 1 to 10 are explained in references 1, 2 to 4, 9 and 10. 
Their values are also taken from references 1, 2 to 4, 9 and 10. 
The required data on bond distances are taken from Landolt and 
Bornstein Tabullen. The data on vibrational frequencies 
necessary to calculate the bond polarizabilities and molecular 
polarizabilities are taken from the data of frequencies of the 
bonds of nearest chemical environment from CRC hand book. 
The data on ‘A’ the reduced electro negativity CR and αM the 
atomic polarizability are taken from the work of Lippincott. [13, 
14]  Molecular polarizability αM ,  diamagnetic susceptibility χM  
for these antimalarial drugs have been calculated by Rao and 
Murthy’s method using equation 9, along with electron 
ionisation cross-section are presented in Table 1 (supplementary 
material). All the above values are evaluated from the molecular 
dynamic method. 
 
It is well known that there is no rigorous theory to explain 
molecular electron ionization cross-section. [15] There are 
several semi empirical results to explain the experimental 
observations of the electron ionization cross-section. Beran and 
Kevan observed proportionality between molecular 
polarizability and susceptibility on one hand, susceptibility and 
electron ionization cross-section on the other hand. When both 
these formulae are put together the dependence of Q on αM or 
χM  becomes expressive. The unsaturated characters of these 
bonds are expected to affect the values. So Rao and Murthy 
modified the equation of Beran and Kevan to equation 10. 
 
The molecular electron ionization cross-section of these 
antimalarial drugs has been calculated using equation 10 of Rao. 
[7] In equation 10, γ is saturation factor and σ is Pauling 
covalency factor. The values of Q obtained from χM of equation 
10 are compiled in Table 1 (supplementary material). The 
dosages and toxic effects of these antimalarial drugs have been 
compiled in Table 2 (supplementary material). The data on the 
dosages and toxic effects have taken from reference 16. The data 
on PB, BA, HL and Log P for these systems is taken from drug 
bank of Wikipedia. [16] These data are used along with Q to 
arrive at a more analytical approach through an algebraic 
expression described in equation 11. 
 
The drug-DNA interaction is mainly based on the electronic 
transfer and electronic polarizability affected during interaction. 
Similarly the process of electron transfer is associated with 
relevant magnetization effects like susceptibility variations. It is 
thus understandable to think of electronic polarization and 
diamagnetic susceptibility variations taking place in a particular 
drug molecule during drug-DNA interaction. Thus a detailed 
study of molecular polarizability and diamagnetic susceptibility 
of these systems are taken up in the present investigation. 
 
Primaquine phosphate or malrid is subjected to magnetic field 
and its diamagnetic susceptibility is tested on Vibrating sample 
Magnetometer at IIT Madras, India.  The diamagnetic 
susceptibility reported is 60.325 micro CGS units where as the 
calculated value is 63.6275 micro CGS units. These studies 
follow electron ionization cross-section Q at molecular level and 
hence the justification of evaluating molecular electron 
ionization cross-section. 
 
Discussion:  
The mean molecular polarizabilities reported by different 
methods are in good agreement with the theoretical values there 
by lending strong support to the strong theoretical basis. 
However the molecular dynamic method seems to be more 
sensitive to conformational changes and hence is taken as 
standard. In a similar manner the diamagnetic susceptibilities 
that are determined from molecular polarizabilities obtained by 
different methods show fairly good agreement. The molecular 
electron ionization cross-sections obtained from susceptibilities 
also show similar good agreement.  
 
The values of PB, BA, log p and HL taken from reference 16 
when used along with Q in the algebraic expression 11 has 
resulted in a constant value of K. This supports the contention of 
the authors of the usefulness of relationship of Q  with all other 
parameters successfully in giving information on dosages etc., In 
fact, the dosage calculation  from given PB, BA, log p, HL and 
K for these systems have taken up as a test of utility of the 
method. 
 
A close look at the Table 2 (supplementary material) on electron 
ionization cross-section and dosage reveal the following. The 
lower the value of Q higher is the activity of the compound. This 
is shown by lower values of Q in mefloquine with Q = 12.2401 
x 10 power 16 square cm. The lower value of Q reveals the 
readiness of the molecule to interact with the DNA and operate 
curatively. It also reveals that more of the effective area is 
available for interaction. However the higher activity is to be 
taken care of in monitoring dosages. It is monitored in a dosage 
of 1250.0 mg per day as a single dose. Any increase of this drug 
is going to cause undesirable electron activity and also cause 
severe depression, anxiety, insomnia, vestibular disorders and 
CNS problems. 
   
Quinine, having a Q value of 13.4404 x 10 power 16 square cm 
is also very active, but less than that of mefloquine. So it is 
monitored in higher dose of 1875.0 mg per day, for seven days. 
But any increase in specified dosage of quinine is leading to skin 
allergy, deafness and mental depression.  
 
Thus, in short, it can be inferred that a drug with lower Q is 
highly active and is need to be monitored in smaller dosages 
whereas a drug of higher Q is not going to give any prominent 
toxic effects even if its dosage is slightly more. Thus it is 
inferred that a structure of drug followed by a measurement of 
fundamental parameters like refractivity, susceptibility and 
electron ionization cross section along with the data on PB, BA, 
log p and HL are helpful in estimating the dosages and toxicity.        Bioinformation by Biomedical Informatics Publishing Group  open access 
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As per the suggestions in recent literature, the correlation of 
electron ionization cross-section with other parameters like 
protein binding, bio availability, Log P and half life was taken 
note of and the dependence of Q on these antimalarial drugs are 
investigated. From the investigations made, a semi algebraic 
expression 11, relating Q with dosage, protein binding etc., 
could be formulated. An evaluation of the dosage from this 
algebraic expression is made and the results are encouraging.   
 
Conclusion:  
The dosages thus obtained through the above   expression 11 
agreed in many systems of medicinal compounds and with order 
of magnitude in other cases. As an example in the case of 
quinine the calculated dosage value is 1125.78 mg per day as 
against the experimental dosage value of 1875.0 mg per day. 
Also in the case of primaquine phosphate the calculated dosage 
value is 30.0 mg per day as against the experimental value of 
26.3 mg per day. The same observations are made in the case of 
mepacrine and atovaquone. The formula is applied to other 
systems like anti-depressants, anti-histamines, anti-inflammatory 
and antibiotics. In almost all the cases the calculated dosage 
values fairly agreed with the experimental values. The above 
formula can be used with fairly reliably to calculate dosages and 
toxic effects of medically important systems. The importance of 
the present investigation involving electron ionization cross-
section and other medicinal parameters lies in the fact of 
predicting the dosages from the available information on 
physical parameters like refractivity, susceptibility and chemical 
structure.  
 
Thus the present method opens a new line of approach to the 
study of drug-DNA interactions besides quantum mechanical 
approaches and other physico-chemical methods that are 
available today. In fact a close look at the molecular structure, 
its refractivities and allied properties show that they alone are 
sufficient to give an insight into the medical activity of the drug 
without  recourse to the highly expensive physico-chemical 
methods and highly cumbersome quantum mechanical 
approaches. The advantage of the present method over quantum 
mechanical method lies in the simplicity of the approach without 
requiring much of computational time and speed.  
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Supplementary material 
 
List of equations used in this article are given below. 
Equation 
  Number
(bL-bT) = A[(XbXc)
1/2(aN/(k-b))
2/3]
δ 
→  (1) 
(bL+2bT) = Cp
j (j) 
nβ σe
1/2 
→  (2) 
αM = Σ [(Ni/3)(bL+2bT)i]  
→  (3) 
Σ α||P =4nA/a0 [(R2/4) + (1/ (2CR2))]
2  
→  (4) 
α|| n = Σj fj αj    
→  (5) 
Σ2α⊥= ndf [(Σj Xj 
2αj ) / (Σj Xj 
2)]  
→  (6) 
αM  = 1/3[Σ α||P+Σ α|| n+Σ2α⊥] 
→  (7) 
αM = [3/(4πNγ)] (R∞)i   
→  (8) 
-χM = γmσ′αM            
      
→  (9) 
Q (in10
-16 cm
2) = 0.278γχM         
→  (10) 
()
( )( )
3
2 / 1
4 / 1
log *
BA PB
P DL
Q
K ⎟
⎟
⎠
⎞
⎜
⎜
⎝
⎛
=
 
→  (11) 
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S. No  Name  α M  χM Q 
I QUININE  DERIVATIVES 
1 Mefloquine  3.8054  60.3965  12.2401 
2 Quinine  4.4145  63.3191  13.4404 
II  7 CHLORO 4 AMINOQUINOLINES 
3 Hydroxy  chloroquine  4.3038  69.9817  14.1826 
4 Amodiaquine  4.31376  72.4452  14.6819 
5 Chloroquine  4.1992  101.0751  20.4834 
III 8  AMINOQUINOLINES 
6 Primaquine  phosphate  3.5331  63.6275  12.8949 
IV 9  AMINOCRIDINES 
7 Mepacrine  5.1947  85.2166  17.2702 
V(a) BIGUANIDES 
8 Proguanil  Hcl  2.9090  60.1668  12.1935 
V(b) DIAMINOPYRIMIDINES 
9 Pyrimethamine  2.7771  71.3448  14.4589 
VI NAPHTHOQUINONES 
10 Atovaquone  4.2213  95.1564  19.2846 
Table 1: Molecular polarizabilities (αM) (x 10 power 23) cubic cm, diamagnetic susceptibilities (χM) (x 10 power 6 CGS units), 
electron ionization cross-section (Q x 10 power 16 square cm) 
 
S. 
no 
 
Name 
 
Q   
 
PB 
 
BA 
 
Log 
P 
 
m 
 
K 
 
K
2m 
 
HL 
 
L 
days 
 
Dosage
16 
I  QUININE DERIVATIVES (KA = 0.9469415)                                                 Cal (mg 
per day) 
Exp (mg 
per day) 
1 Mefloquine  12.2401 0.98 0.1  3.81 30.6 
 
1.01634  0.0355  2 week  14  484.45  1250  
 
2 
 
Quinine 
 
13.4404 
 
0.95 
 
0.88 
 
2.53 
 
3.58 
 
 
0.87754 
 
0.676 
 
18 hrs 
 
0.75 
 
1125.78 
 
1875 [17] 
II  7 CHLORO 4 AMINOQUINOLINES (KA = 2.3964)                                 
3 Hydroxy-
Chloro quine 
14.1826 - - - -  -  -  -  -  -  400  for  7 
days  
4  Amodia - quine  14.6819  -  -  4.33  -  -  -  5.2           
- 
- 1200 
5 Chloro  -quine  20.4834 0.55  0.9  4.47  6.06  2.3964  39876.25086  1 - 2 
months 
30 14.6749  71.4285 
[18] 
III  8 AMINOQUINOLINES (KA = 1.08581)                                                           
6 Primaquine 
Phosphate 
12.8949  0.5  0.25 2.14 24  1.08581  52.0311  3.7 - 4.2 
hrs 
0.31 30  26.3   
IV  9 AMINOCRIDINES (KA = 0.95817)                                                                 
7  Mepacrine  17.2702  0.8 0.5 5.38
8 
7.5 
 
0.95817  0.4472  5 - 14 
days 
5 60  100 
V(a) BIGUANIDES  (KA = 1.1033)    
8  Proguanil Hcl         
12.1935 
0.75 0.5  2.55
8 
8 1.1033  5.33657  20  hrs  0.83
3 
120 100 
V(b) DIAMINOPYRIMIDINES  (KA = 1.31159)     
9 Pyrimeth  -
amine 
14.4589 0.87  0.9  2.60
7 
3.83
141 
1.31159 7.99251  96  hrs  4  17  25 
VI NAPHTHOQUINONES  (KA = 0.89243)     
10  Atova-quone  19.2846  0.99 0.47 5.25  6.38  0.89243  0.23358  2.2 - 3.2 
days  
2.2 309.91 750  twice 
for 21 days 
 Table 2: Dosage. Q determined by molecular vibration method
 